A programme looking to advance the understanding of how cancer develops has been backed with £50 million. Global biopharma company GSK has invested up to £50 million in a collaboration with Oxford ...

It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

New cancer vaccine to stop disease before it takes hold in the body - Pharmaceutical giant GSK and the University of Oxford ...

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed to highlight the intuitive interconnectedness of the natural world; but it ...